Join Growin Stock Community!

海昌生技7814.TW Overview

TW StockBiotech. & Medical
(No presentation for 7814)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

海昌生技（7814）Overall Performance

海昌生技（7814）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

海昌生技（7814） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

海昌生技（7814）Key Information

海昌生技（7814）Profile

海昌生技（7814）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.60
PE Ratio (TTM)
67.71
Forward PE
-
PS Ratio (TTM)
10.84
PB Ratio
5.61
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
77.05%
Net Margin
16.01%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.60
PE Ratio (TTM)
67.71
Forward PE
-
PS Ratio (TTM)
10.84
PB Ratio
5.61
Price-to-FCF
-
Gross Margin
77.05%
Net Margin
16.01%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
default symbol

7814

海昌生技

40.55D

-2.71%

(-0.03)

  • When is 7814's latest earnings report released?

    The most recent financial report for 海昌生技 (7814) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 7814's short-term business performance and financial health. For the latest updates on 7814's earnings releases, visit this page regularly.

  • How much cash does 7814 have?

    At the end of the period, 海昌生技 (7814) held Total Cash and Cash Equivalents of 50.81M, accounting for 0.16 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 7814 go with three margins increasing?

    In the latest report, 海昌生技 (7814) achieved the “three margins increasing” benchmark, with a gross margin of 71.15%%, operating margin of 8.14%%, and net margin of 11.62%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 7814's profit trajectory and future growth potential.